Please see Full Prescribing Information: https://bit.ly/2X5Kfg8
Please see Patient Product Information: https://bit.ly/2X5QsZB
MYRBETRIQ® (mirabegron extended-release tablets) is a prescription medicine for adults used to treat overactive bladder (OAB) with symptoms of urgency, frequency and leakage. We’ve created this page and resource to help you on your journey with overactive bladder (OAB) with symptoms of urgency, frequency and leakage and to help you advocate for yourself! We want you to be up-to-date, in-the-know, and totally informed about how you may manage your OAB. And as always, make sure to talk to your doctor to see if this treatment is right for you. Audiences only.
– While comments are off on this page, we still ask users to be respectful to others on our platforms. The community managers for this page are not doctors and therefore will not provide medical advice or act as a replacement for a healthcare provider, but we can connect you with additional resources so that you can learn more about overactive bladder (OAB). You can visit Myrbetriq.com for additional resources and information, so that you can learn more about OAB, and talk to your doctor to see if Myrbetriq may be right for you.
– The content posted on our social channels is NOT professional medical advice and serves educational and informational purposes. The content is not intended to compare treatment options, discuss safety issues or report side effects associated with Astellas treatments, or any other treatments.
– Astellas does not control the content of other Facebook profiles sharing content from this page and is not responsible for any non-Astellas sources, including but not limited to the content, the accuracy of the content, and/or the manner in which such content is communicated. Please contact your healthcare provider if you think you have experienced a reaction from an Astellas product. To report an adverse event or product complaint about an Astellas product, please contact us at AstellasAnswers.com. If you experience a side effect while using prescription drugs, you are encouraged to report it to the FDA. To do so, visit http://www.fda.gov/medwatch or call 1-800-FDA-1088. For additional information on how Astellas may use your content or personal information visit https://www.astellas.com/us/privacy-policy
Myrbetriq® is a registered trademark of Astellas Pharma Inc. All other trademarks or registered trademarks are the property of their respective owners.
